مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

8,780
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

COMPARING EFFICACY AND SIDE EFFECTS OF PD-GRASTIM AND NEUPOGEN FOR PREVENTION OF NEUTROPENIA AFTER CHEMOTHERAPY IN CHILDREN

Pages

  143-148

Abstract

 Conclusion: Pd-Grastim may be preferred to Neupogen in Iran, because of the same effectiveness but lower cost. Methods: Absolute Neutrophil count (ANC), total WBC, platelet count (on the 15th day of CHEMOTHERAPY), and event of FEVER and NEUTROPENIA in this period, were measured after 60 courses of CHEMOTHERAPY and 4 days of G-CSF, in two separate but the same patients groups, Pd-Grastim (group 1) and Neupogen (group 2). Findings: Mean values of WBC count, ANC, and platelet count were similar (P.V.>0.05). No significant difference was observed for episodes of NEUTROPENIA (ANC<500), event of FEVER and NEUTROPENIA, and days of hospitalization between these groups. Effectiveness and also side effects of Pd-Grastim and Neupogen were similar. Lower cost of Pd-Grastim was the only significant difference between these two forms of G-CSF. Background: G-CSF is one of the new medications that may reduce duration and severity of NEUTROPENIA after CHEMOTHERAPY. Two forms of G-CSF are now available in Iran: Neupogen (original from), and new production of Iran named Pd-Grastim. We decided to compare the efficacy and side effects of these two of the drug.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    MOAFI, A.R., SOHEYLIPOUR, F., AMINI, A., & BEHESHTI, M.. (2006). COMPARING EFFICACY AND SIDE EFFECTS OF PD-GRASTIM AND NEUPOGEN FOR PREVENTION OF NEUTROPENIA AFTER CHEMOTHERAPY IN CHILDREN. IRANIAN JOURNAL OF PEDIATRICS, 16(2), 143-148. SID. https://sid.ir/paper/75981/en

    Vancouver: Copy

    MOAFI A.R., SOHEYLIPOUR F., AMINI A., BEHESHTI M.. COMPARING EFFICACY AND SIDE EFFECTS OF PD-GRASTIM AND NEUPOGEN FOR PREVENTION OF NEUTROPENIA AFTER CHEMOTHERAPY IN CHILDREN. IRANIAN JOURNAL OF PEDIATRICS[Internet]. 2006;16(2):143-148. Available from: https://sid.ir/paper/75981/en

    IEEE: Copy

    A.R. MOAFI, F. SOHEYLIPOUR, A. AMINI, and M. BEHESHTI, “COMPARING EFFICACY AND SIDE EFFECTS OF PD-GRASTIM AND NEUPOGEN FOR PREVENTION OF NEUTROPENIA AFTER CHEMOTHERAPY IN CHILDREN,” IRANIAN JOURNAL OF PEDIATRICS, vol. 16, no. 2, pp. 143–148, 2006, [Online]. Available: https://sid.ir/paper/75981/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button